Sara Salvador | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Dr. Sara Salvador | Pharmacogenomics and Personalized Medicine | Best Researcher Award

Gregorio Maranon University Hospital | Spain

Author Profile

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Since 2017, I have been dedicated to advancing the field of pharmacogenetics, beginning as a research assistant and progressing through to postdoctoral researcher at the Pharmacogenetics Laboratory of the Gregorio MaraĆ±Ć³n General University Hospital. My journey started with foundational research roles and evolved into leadership positions within various pharmacogenomic studies.

PROFESSIONAL ENDEAVORS

Starting as a research assistant, I gradually transitioned to roles as a predoctoral and postdoctoral researcher, accumulating invaluable experience and expertise in pharmacogenetics. My work has been primarily focused on pharmacogenomic studies in diverse medical areas such as colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENMICS AND PERSONALIZED MEDICINE

Throughout my career, I have actively contributed to 21 publications in pharmacogenomics, with a particular emphasis on colorectal cancer, multiple sclerosis, psychiatry, and intestinal inflammatory diseases. Of these publications, I served as the first author for 14, showcasing my significant contributions to the field. Notably, my doctoral thesis in 2020 centered on intestinal inflammatory disease, underscoring my commitment to advancing knowledge in this area.

IMPACT AND INFLUENCE

My contributions have not gone unnoticed, as evidenced by receiving the AEFA (Spanish Clinical Laboratory Association) award for quality and innovation in 2019. Additionally, my research has been recognized through presentations at 20 national and international conferences, including 5 oral communications. I have been honored with the best oral communication award at three conferences, highlighting the impact of my work.

ACADEMIC CITES

My research has contributed to the academic discourse, with citations in various publications, further validating the significance and influence of my work in pharmacogenetics awards and related fields.

LEGACY AND FUTURE CONTRIBUTIONS

As an active member of the Spanish Society of Pharmacogenetics awards and the Spanish Association of Human Genetics, I continue to contribute to the advancement and dissemination of knowledge in these critical areas of public health. My ongoing commitment to research and collaboration ensures that my contributions will continue to shape the future of pharmacogenetics.

NOTABLE PUBLICATIONS

Hongsheng Dai | Pharmacogneomics and Personalized medicine | Best Researcher AwardĀ 

Prof Hongsheng Dai | Pharmacogneomics and personalized medicine | Best Researcher AwardĀ 

Newcastle University | United Kingdom

Author Profile

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Hongsheng Dai pursued his academic journey with a B.Sc. in Applied Mathematics from Tianjin University, followed by an M.Sc. in Statistics from Beijing University, where he focused on survival analysis. He furthered his studies with a D.Phil. in Statistics from the University of Oxford, specializing in perfect Monte Carlo simulation techniques.

Professional Endeavors

Dai's professional journey showcases a progression from lecturer roles to professorships, demonstrating his dedication and expertise in the field of statistics. He held positions at various prestigious institutions, including Lancaster University, Brighton University, and the University of Essex, before assuming his current role as a Professor in Statistics at Newcastle University.

Contributions and Research Focus on Pharmacogenomics and personalized medicine

Dai's research interests encompass a broad spectrum of statistical methodologies, including exact Monte Carlo simulations, Bayesian computational methods, graphical models, mixture models, and survival analysis. His notable contributions include advancements in coupling from the past, path-space rejection sampling, Bayesian fusion, and nonparametric survival analysis for both censored and truncated bivariate data.

Impact and Influence

Dai's research has garnered significant recognition, as evidenced by the grants he has secured, such as the ERC Synergy Grant and EPSRC funding. His work on responsible AI for gender and ethnic labor market equality reflects his commitment to addressing societal challenges through statistical methodologies.

Academic Citations

Dai's work has likely garnered citations in various academic publications, particularly in the fields of statistics, computational methods, and applied mathematics, given the breadth and depth of his research contributions.

Legacy and Future Contributions

Dai's legacy lies in his substantial contributions to statistical methodologies, particularly in exact Monte Carlo simulations and survival analysis. His interdisciplinary collaborations and innovative approaches have positioned him as a leader in the field. Looking forward, Dai is poised to continue making significant contributions to statistical research, with potential applications in diverse domains.

Notable Publications

Balancing Gender Bias in Job Advertisements With Text-Level Bias Mitigation 2022(7)

The role of insulators and transcription in 3D chromatin organization of flies 2022(18)